News
NEW YORK, April 2, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (HOTH), a patient-focused clinical-stage biopharmaceutical company, today announced its collaboration with Washington University ...
NEW YORK, March 26, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on developing first-in-class therapies for allergic and inflammatory diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback